Biotech News
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
Enables high-throughput assessment of thousands of antibodies per day to support AI/ML-driven discovery workflows Turnaround time starting in as little as five days SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 28, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value
